Episodes
Wednesday Jun 29, 2022
Meeting the unmet needs of patients with new medicines | Ep22
Wednesday Jun 29, 2022
Wednesday Jun 29, 2022
Andy Yates Chief Scientific officer at Artelo Biosciences joins the show this week to share his story as well as the innovative programmes Artelo are currently running.
Find out how after dropping out of school at 16 Andy went on to do a Pharmacy degree and later a PhD which helped him explore his love of science and drug development.
Andy and the team at Artelo have been exploring the endocannabinoid therapeutic potential.
Tune in to hear about the various drugs Artelo have formulated including one to treat Cancer Anorexia and Cachexia Syndrome (CACS).
To contact Andy email him at andy@artelobio.com
Connect on LinkedIn https://www.linkedin.com/in/andy-y-4985aa1/
Check out their website https://artelobio.com/who-we-are/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.